Back to UBS Group AG UBS Group AG

TRAWTRAW
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in TRAWS PHARMA INC

UBS Group AG holds 3,451 shares of TRAW (TRAWS PHARMA INC), worth $2,909 as of 2026-Q2. The position was decreased (-14.8% shares).

Current Value

$2,909

Current Shares

3,451

Total Value Change

-$795

Total Shares Change

+2,821

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3,451
-14.8%
$2,9090.0%$0.84
0
2026-Q1
Decreased
4,053
-47.5%
$7,4170.0%$1.65
0
2025-Q4
Increased
7,722
+1286x
$8,7260.0%$1.09
18
2025-Q3
Decreased
6
-99.8%
$110.0%$1.89
0
2025-Q2
Decreased
3,006
-79.0%
$4,4490.0%$1.43
0
2025-Q1
Increased
14,323
+1710.8%
$32,9430.0%$2.40
22
2024-Q4
Increased
791
+25.6%
$7,0240.0%$8.42
13
2024-Q3
New
630
-
$3,7040.0%$5.74
21

Other major holders of TRAW: ADAGE CAPITAL PARTNERS GP, L.L.C., Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used